The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Richard K. Burt

Division of Immunotherapy

Department of Medicine

Northwestern University Feinberg School of Medicine

Chicago

USA

[email]@northwestern.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA. 2003 - 2013

References

  1. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Burt, R.K., Oliveira, M.C., Shah, S.J., Moraes, D.A., Simoes, B., Gheorghiade, M., Schroeder, J., Ruderman, E., Farge, D., Chai, Z.J., Marjanovic, Z., Jain, S., Morgan, A., Milanetti, F., Han, X., Jovanovic, B., Helenowski, I.B., Voltarelli, J. Lancet (2013) [Pubmed]
  2. Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: a preclinical study. Burt, R.K., Chen, Y.H., Verda, L., Lucena, C., Navale, S., Johnson, J., Han, X., Lomasney, J., Baker, J.M., Ngai, K.L., Kino, A., Carr, J., Kajstura, J., Anversa, P. Circ. Res. (2012) [Pubmed]
  3. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Burt, R.K., Shah, S.J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., Jovanovic, B., Milanetti, F., Jain, S., Boyce, K., Morgan, A., Carr, J., Barr, W. Lancet (2011) [Pubmed]
  4. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Burt, R.K., Craig, R.M., Milanetti, F., Quigley, K., Gozdziak, P., Bucha, J., Testori, A., Halverson, A., Verda, L., de Villiers, W.J., Jovanovic, B., Oyama, Y. Blood (2010) [Pubmed]
  5. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Burt, R.K., Testori, A., Oyama, Y., Rodriguez, H.E., Yaung, K., Villa, M., Bucha, J.M., Milanetti, F., Sheehan, J., Rajamannan, N., Pearce, W.H. Bone Marrow Transplant. (2010) [Pubmed]
  6. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Burt, R.K., Loh, Y., Cohen, B., Stefoski, D., Stefosky, D., Balabanov, R., Katsamakis, G., Oyama, Y., Russell, E.J., Stern, J., Muraro, P., Rose, J., Testori, A., Bucha, J., Jovanovic, B., Milanetti, F., Storek, J., Voltarelli, J.C., Burns, W.H. Lancet. Neurol (2009) [Pubmed]
  7. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. Burt, R.K., Loh, Y., Pearce, W., Beohar, N., Barr, W.G., Craig, R., Wen, Y., Rapp, J.A., Kessler, J. JAMA (2008) [Pubmed]
  8. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. Burt, R.K., Testori, A., Testor, A., Craig, R., Cohen, B., Suffit, R., Barr, W. J. Autoimmun. (2008) [Pubmed]
  9. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Burt, R.K., Traynor, A., Statkute, L., Barr, W.G., Rosa, R., Schroeder, J., Verda, L., Krosnjar, N., Quigley, K., Yaung, K., Villa Bs, M., Takahashi, M., Jovanovic, B., Oyama, Y. JAMA (2006) [Pubmed]
  10. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Burt, R.K., Marmont, A., Oyama, Y., Slavin, S., Arnold, R., Hiepe, F., Fassas, A., Snowden, J., Schuening, F., Myint, H., Patel, D.D., Collier, D., Heslop, H., Krance, R., Statkute, L., Verda, L., Traynor, A., Kozak, T., Hintzen, R.Q., Rose, J.W., Voltarelli, J., Loh, Y., Territo, M., Cohen, B.A., Craig, R.M., Varga, J., Barr, W.G. Arthritis Rheum. (2006) [Pubmed]
  11. Hematopoietic stem cell transplantation for multiple sclerosis. Burt, R.K., Cohen, B., Rose, J., Petersen, F., Oyama, Y., Stefoski, D., Katsamakis, G., Carrier, E., Kozak, T., Muraro, P.A., Martin, R., Hintzen, R., Slavin, S., Karussis, D., Haggiag, S., Voltarelli, J.C., Ellison, G.W., Jovanovic, B., Popat, U., McGuirk, J., Statkute, L., Verda, L., Haas, J., Arnold, R. Arch. Neurol. (2005) [Pubmed]
  12. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Burt, R.K., Oyama, Y., Verda, L., Quigley, K., Brush, M., Yaung, K., Statkute, L., Traynor, A., Barr, W.G. Arthritis Rheum. (2004) [Pubmed]
  13. Non-myeloablative stem cell transplantation for autoimmune diseases. Burt, R.K., Verda, L., Oyama, Y., Statkute, L., Slavin, S. Springer Semin. Immunopathol. (2004) [Pubmed]
  14. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Burt, R.K., Cohen, B.A., Russell, E., Spero, K., Joshi, A., Oyama, Y., Karpus, W.J., Luo, K., Jovanovic, B., Traynor, A., Karlin, K., Stefoski, D., Burns, W.H. Blood (2003) [Pubmed]
 
WikiGenes - Universities